ECO ANIMAL HEALTH GROUP PLC

Director's Dealing • Jul 15, 2025

National Storage Mechanism | Additional information

RNS Number : 1599R

Eco Animal Health Group PLC

15 July 2025

15 July 2025  

ECO Animal Health Group plc

("ECO" or the "Company")

Share Purchase by Executive Director

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that on 15 July 2025 David Hallas, Chief Executive Officer, purchased 29,897 ordinary shares in the Company ("Ordinary Shares") at 66.90 pence per Ordinary Share. Following this, Mr Hallas holds 189,876 Ordinary Shares, representing 0.27 per cent. of the Company's issued share capital.

-Ends-

For further information please contact:

ECO Animal Health Group plc David Hallas (CEO) Christopher Wilks (CFO)	020 8447 8899
Singer Capital Markets (Nominated Adviser & Joint Broker) Phil Davies Sam Butcher	020 7496 3000
Investec (Joint Broker) Gary Clarence Lydia Zychowska	020 7597 5970
Equity Development Hannah Crowe Matt Evans	020 7065 2692
ICR Consilium (Financial PR) Mary-Jane Elliott Jessica Hodgson	020 3709 5700 ecoanimalhealth@consilium-comms.com

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. 

Click here for more information: https://ecoanimalhealth.com

PDMR Notification

1.           

Details of the person discharging managerial responsibilities / person closely associated

a.            

Name

David Hallas

2.            

Reason for the notification

a.            

Position/status

Chief Executive Officer

b.            

Initial notification

/Amendment

Initial notification

3.            

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.           

Name

Eco Animal Health Group Plc

b.           

LEI

2138009XN9DJ3YP70B55

4.            

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.            

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5p each.

GB0032036807

b.            

Nature of the transaction

Purchase of Ordinary Shares

c.            

Price(s) and volume(s)

Price(s)	Volume(s)
66.8953p	29,897

d.            

Aggregated information

Aggregated volume

Price  

n/a

e.            

Date of the transaction

15 July 2025

f.            

Place of the transaction

London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBBGDRUUBDGUU